|
Volumn 15, Issue 9, 1996, Pages 948-954
|
Methotrexate can halt the progression of bronchiolitis obliterans syndrome in lung transplant recipients
a a a a |
Author keywords
[No Author keywords available]
|
Indexed keywords
AZATHIOPRINE;
CYCLOSPORIN A;
FOLIC ACID;
HYPERIMMUNE GLOBULIN;
LYMPHOCYTE ANTIBODY;
METHOTREXATE;
METHYLPREDNISOLONE;
PREDNISONE;
STEROID;
TACROLIMUS;
ADULT;
ARTICLE;
BLOOD TOXICITY;
BONE MARROW TOXICITY;
BRONCHIOLITIS;
BURKHOLDERIA CEPACIA;
CLINICAL ARTICLE;
CLINICAL TRIAL;
CYSTIC FIBROSIS;
FEMALE;
FORCED EXPIRATORY VOLUME;
GASTROINTESTINAL SYMPTOM;
GRAFT REJECTION;
HEART TRANSPLANTATION;
HUMAN;
LEUKOPENIA;
LUNG EMPHYSEMA;
LUNG TOXICITY;
LUNG TRANSPLANTATION;
MALAISE;
MALE;
NAUSEA;
ORAL DRUG ADMINISTRATION;
PRIORITY JOURNAL;
PULMONARY HYPERTENSION;
ADULT;
BRONCHIOLITIS OBLITERANS;
DRUG ADMINISTRATION SCHEDULE;
FEMALE;
FORCED EXPIRATORY VOLUME;
GRAFT REJECTION;
HUMANS;
IMMUNOSUPPRESSIVE AGENTS;
LUNG TRANSPLANTATION;
MALE;
METHOTREXATE;
MIDDLE AGED;
PILOT PROJECTS;
RETROSPECTIVE STUDIES;
SPIROMETRY;
SYNDROME;
TREATMENT OUTCOME;
|
EID: 0029778747
PISSN: 10532498
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
Times cited : (86)
|
References (0)
|